Skip to main content

Lilly Tops Q2 Earnings, Chooses IPO Path for Elanco

Eli Lilly & Company reported second-quarter 2018 adjusted earnings per share of $1.50.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.